Education
About Us
Working with TipRanks
Follow Us
MiMedx Group (MDXG)
NASDAQ:MDXG
Total Valuation
MiMedx Group has a market cap or net worth of $979.27M. The enterprise value is ―.
Market Cap$979.27M
Enterprise Value―
Share Statistics
MiMedx Group has 147,702,130 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding147,702,130
Owned by Insiders2.06%
Owned by Institutions37.28%
Financial Efficiency
MiMedx Group’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 19.67%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.16
Return on Invested Capital (ROIC)19.67%
Return on Capital Employed (ROCE)0.27
Revenue Per Employee416.82K
Profits Per Employee50.18K
Employee Count837
Asset Turnover1.32
Inventory Turnover2.52
Valuation Ratios
The current PE Ratio of MiMedx Group is 33.33. MiMedx Group’s PEG ratio is -7.04.
PE Ratio33.33
PS Ratio0.00
PB Ratio4.81
Price to Fair Value7.32
Price to FCF14.31
Price to Operating Cash Flow14.43
PEG Ratio-7.04
Income Statement
In the last 12 months, MiMedx Group had revenue of 348.88M and earned 42.42M in profits. Earnings per share was 0.29.
Revenue348.88M
Gross Profit288.81M
Operating Income58.87M
Pretax Income57.29M
Net Income42.42M
EBITDA64.34M
Earnings Per Share (EPS)0.29
Cash Flow
In the last 12 months, operating cash flow was 67.55M and capital expenditures 1.14M, giving a free cash flow of 68.32M billion.
Operating Cash Flow67.55M
Free Cash Flow68.32M
Free Cash Flow per Share0.46
Dividends & Yields
MiMedx Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.77
52-Week Price Change-9.85%
50-Day Moving Average7.13
200-Day Moving Average7.51
Relative Strength Index (RSI)45.25
Average Volume (3m)776.83K
Important Dates
MiMedx Group upcoming earnings date is Aug 5, 2025, TBA Not Confirmed.
Last Earnings DateApr 30, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend Date―
Financial Position
MiMedx Group as a current ratio of 4.21, with Debt / Equity ratio of 9.20%
Current Ratio4.21
Quick Ratio3.69
Debt to Market Cap<0.01
Net Debt to EBITDA-1.33
Interest Coverage Ratio58.51
Taxes
In the past 12 months, MiMedx Group has paid 15.30M in taxes.
Income Tax15.30M
Effective Tax Rate0.27
Enterprise Valuation
MiMedx Group EV to EBITDA ratio is 20.65, with an EV/FCF ratio of 20.59.
EV to Sales3.81
EV to EBITDA20.65
EV to Free Cash Flow20.59
EV to Operating Cash Flow20.07
Balance Sheet
MiMedx Group has $106.43M in cash and marketable securities with $18.66M in debt, giving a net cash position of -$87.77M billion.
Cash & Marketable Securities$106.43M
Total Debt$18.66M
Net Cash-$87.77M
Net Cash Per Share-$0.59
Tangible Book Value Per Share$1.10
Margins
Gross margin is 81.88%, with operating margin of 16.87%, and net profit margin of 12.16%.
Gross Margin81.88%
Operating Margin16.87%
Pretax Margin16.42%
Net Profit Margin12.16%
EBITDA Margin18.44%
EBIT Margin16.71%
Analyst Forecast
The average price target for MiMedx Group is $12.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$12.00
Price Target Upside77.25% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast5.34%
EPS Growth Forecast-50.52%